Takeda joins 5th ADC Summit to discuss ADCETRIS development

Top Quote SMi reports (05.02.2016, London UK) ADCETRIS Global Medical Lead joins expert speaker panel at the 5th annual ADC Summit in London. End Quote
  • (1888PressRelease) February 10, 2016 - SMi is pleased to announce that Ashish Gautam, Global Medical Lead - ADCETRIS from Takeda, has joined the expert speaker line-up at the 5th annual ADC Summit taking place on 23 - 24 May in London, UK. Registration to the conference is now live on the website, with a special discount of 400 for bookings before 29 February. Visit http://www.adcsummit.com/1888 for more details.

    Ashish will be opening Day Two of the conference with a keynote address entitled "ADCETRIS developed to treat Hodgkin Lymphoma" and will explore:
    Development of ADCETRIS - the Takeda and Seattle Genetics alliance
    Exploring the mechanism pathway of ADCETRIS
    Data published to date from ADCETRIS registration studies
    Ongoing ADCETRIS clinical development

    Join industry leaders as they share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.

    Other presentations include:
    Challenges and lessons learnt in ADC CMC development and outsourcing
    Jens Lorhmann, Senior Global Program Manager, Novartis

    Advancement in antibody grug conjugates: a step closer to magic bullets in war against cancer
    Rakesh Dixit, Vice President, R&D, Medimmune

    Impact of drug loading on ADC target binding and cytotoxicity
    Debbie Meyer, Senior Principal Scientist, Pfizer

    Predicting tissue distribution and clearance of antibody formats to improve selectivity of targeted therapies
    Ben-Fillippo Krippendeorff, Principal Scientist, Roche

    The design, synthesis and scale-up of an ADC tubulysin
    Jeremy Parker, Principal Scientist, Pharmaceutical Development, AstraZeneca and many more.

    The full speaker lineup can be found on http://www.adcsummit.com/1888

    In addition to the conference, the event will feature two exclusive half-day post-conference workshops held on the 25 May 2016:
    1. ADC payloads: Availability and mechanisms of action
    Hosted by Femtogenix and King's Cross London
    2. Developments in high potency API manufacturing
    Hosted by SKAN AG

    For more information or to register visit the event website at www.adcsummit.com/1888
    To take advantage of the EARLY BIRD OFFER register before 29 February to save 400 off the conference price.

    For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick ( @ ) smi-online dot co dot uk

    For delegate bookings contact Fateja Begum on +44 (0) 20 7827 6184 or email fbegum ( @ ) smi-online dot co dot uk
    For media enquiries contact Honey de Gracia on +44 (0) 20 7827 6102 or email hdegracia ( @ ) smi-online dot co dot uk

    5th ADC Summit
    23-24 May 2016
    London, UK
    Event Website: www.adcsummit.com/1888

  • FB Icon Twitter Icon In-Icon
Contact Information